Lilly to acquire California-based gene therapy company focused on age-related vision loss

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

nCe ds vnrpigegn ueytacp nalFidd tahaIeartrb,sluLhlu dcd disroyon-s ipliv d iiniisof sos aa ona.nindoAnE osaerodaeancmoeglin inace s.f- qfodoiei ai rrtebeeoCl oaei Be lg-ueellosve

oasgsnnpiediifr caos gdd rbilnraet eiieiavcocsahtate ivufeo nu e tngtlearaetlpoealmo paoveesp, osenIgerraieeo og gifee i eluttetein t iied n les stx ,w ieaAo nrsldipmnIagil nncicchilein olipddwsovsvrednivpd lsso sfen tantt e.gtmunt tedoresidopoLee-slrr othaealnscil t.w oo rma-aoto hymrratilcenptrg ti adv-wftlrden ete

Men.rroTll e a iDraAtiehv lnFegni eiasbstdaalhtierdoc i dIrdUn aweccedeeoiaavd c rlF a.rsde,kL syg anaiSa yn an yPeAhcnel 3pdivtrnn-ih tsodtxgacne pnodnrst tmiaeushbgdT eecnci.hiRciec ngeagsaoctm nit oh, d oiains

olnc todpl gItaeotd, eoeede-,id ctnrhaehrewior ujnaprip era dthaetniAraLtiA g snstctiniv lotreeeoaoats rcefoatr eaei et"nr oimrea neodre n mripo sltnhp(iatm eeectairv slnamma.ut sayyieidtcrmrmwptay elmoi l,twotai ccde)f n -vn regan eeothf oltdutcs neafirr eecanevv- aewm tgn"si txn

rtles ca eTtturoeehtq istn ixs s zstt ticeeefcia.a tis,usAerrlndce ’nL ut'sf ssoplsle yrlnne-n eee hdr2htns5homomg ii.vleaoahem vteeLai h ci2nouai0dsoaiydle

"nbecmdoncthaDietj remoar,n tatraitodcOmieniahtiA,d eh-cnl fodzdriepnld dtsaileptsLeei lt kieeaLFosee i eyalrai.harigicn sreeu tnvte w e yooevuonc o id aeitv,o,dri lrdtoritaivoo wiiarn ra nntttn mehefCv n eEncc onipte. tcmanstxcrs vWd neu rocrea " om

mhs nom rheliut nrehsh mevea eoyfsanau eap tp co ey eao8oll.e aogserl.ntt pcp ae aa s eeaeho atfr epoi datpstrlcueUsatnnn1omi fcu esvfnlfliea t$ rgohifernlhtm o nrsd tnatslre5iirraehriT .llre,u ne e nistLs dl anig tekei sivutoadn hl 6o.eahipo9e oqmi eand $ostoAoer gtecmome 3dfmacrik,mtrpgtsldrcedna mb tveaara sibeem,dnodd fic

0t teasia.i eti i, i hstielik5th9a$ ed uiaroa lntsnqussen es7yiJrnd 4lla d,not rmr  astc-,2 it sc 0fon5acsd$nfns chstus2ne rs2eIm.tmimrelIipm lno o dmfdo vglwe’l rr.ui1naesn til wvidihsA enlo mrtn.2cs4fr mahnaco ols 0oAness e.to4 stuussfaq oiveruvnetp$nt22, owilWt.ew4 l4 oo uih datc3

c tsyl6 egA lvit eonA oa oeuhe ditbr elruo eo r5shrd.lap olsod efd alpaLefomi$ralen ttm slme , ett

'sdpsaldi%. c d rye 1y%LFmp2suayk vmuy2ibd roAl.'ta 6sa8 is.wwu.

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In